Variablea | non-RSCL (n = 162) | RSCL (n = 53) | p-valueb |
---|---|---|---|
All patients: | 33 (20.4 %) | 24 (45.3 %) | 0.0004 |
Inflammatory status preoperatively: | |||
No inflammation | 8 (10.7 %) | 5 (50.0 %) | 0.0012 |
Sepsis | 10 (19.9 %) | 10 (35.7 %) | 0.0520 |
Severe sepsis/septic shock | 15 (53.6 %) | 9 (60.0 %) | 0.6858 |
Patient Characteristics: | |||
Male Gender | 25 (26.6 %) | 13 (44.8 %) | 0.0632 |
Female Gender | 8 (11.7 %) | 11 (45.8 %) | 0.0004 |
Race, White | 27 (21.1 %) | 20 (43.5 %) | 0.0034 |
Age (≥70) | 20 (36.4 %) | 10 (52.6 %) | 0.2131 |
No comorbidities | 17 (23.9 %) | 11 (47.8 %) | 0.0295 |
1 comorbidity | 0 (0.0 %) | 1 (50.0 %) | 0.0016 |
2 comorbidities | 3 (21.4 %) | 3 (42.9 %) | 0.3055 |
≥3 comorbidities | 13 (22.4 %) | 9 (42.9 %) | 0.0733 |
Lethal Triad: | |||
Hypothermia (temp ≤ 35C) | 8 (33.3 %) | 3 (42.9 %) | 0.6431 |
Coagulopathy (INR ≥ 1.7) | 5 (38.5 %) | 5 (55.6 %) | 0.4285 |
Acidosis (pH ≤ 7.25) | 12 (50.0 %) | 10 (55.6 %) | 0.7213 |
Patient characteristics: | |||
ASA score, 1 or 2 | 0 (0.0 %) | 0 (0.0 %) | - |
ASA score, 3 | 5 (7.7 %) | 1 (12.5 %) | 0.6404 |
ASA score, 4 or 5 | 28 (37.8 %) | 23 (51.1 %) | 0.1559 |
Lactate (≥3) | 13 (40.6 %) | 11 (42.3 %) | 0.8970 |